Japan's Sawai Pharma to buy US generics maker

OSAKA — Sawai Pharmaceutical will buy the generics business of U.S. drugmaker Upsher-Smith Laboratories for $1.05 billion, the Japanese company said Thursday, eager to make up for lost time after its first push into the American market stalled.
( read original story …)


Related Post

The Latest: Japan lifts all tsunami warnings and a...
views 69
All tsunami warnings and advisories have been lift...
Russia's Putin and Japan's Abe tell N. K...
views 110
April 27 Russian President Vladimir Putin and Japa...
Evening With Yoshiki Premium Dinner Show 2017 Begi...
views 88
On Saturday, August 26, 2017, the YOSHIKI Premium ...
China bank fraud base found in Japan
views 156
The base for a group of people involved in a Chine...
Japan hotelier's Nanjing massacre denial ange...
views 78
A Japanese hotel chain has come under fire for its...
Japan's banks being forced to embrace fintech
views 176
The bank hopes the system can help it to drastical...
Head of Japan's largest advertising agency re...
views 72
The head of Japan's largest advertising agency has...
Mitsubishi UFJ: The Quintessential Megabank At A G...
views 95
Mitsubishi UFJ is the biggest Japanese retail and ...
Sansiri teams up with Tokyu Corp
views 60
The joint venture plans to develop its first proje...
Japan keeps upbeat economy view, signals second lo...
views 47
Japan's government maintained its upbeat view on t...